Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole vs Voriconazole in Chronic Pulmonary Aspergillosis
NCT04824417Phase 3Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Mar 2021
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of voriconazole in chronic pulmonary aspergillosis (CPA), sponsored by Post Graduate Institute of Medical Education and Research. Started Mar 2021; status: completed.
02
Drugs
voriconazole
03
Conditions
chronic pulmonary aspergillosis (CPA)
Beyond the preview
Go deeper on NCT04824417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04824417.